We must consider the full spectrum of patients culture, trauma, mental health, structural advantages and disadvantages, lifestyle, and economic resources when considering which medications can effectively address their addiction in a long-term, sustainable way that benefits overall health and restores agency
GHK-Cu is often studied in combination with BPC-157 or NAD+ in regenerative and anti-aging protocols
These combination products allow laboratories to evaluate multi-peptide research protocols alongside single-compound BPC-157 studies within the same experimental program
GLP-1s: Driving Changes in Buying Behavior 5.3% reduction in grocery spend 1 8% reduction in fast food, coffee chain and limited-service restaurant spend 2 10.1% reduction in savory snack spend 3 Up to 40% reduction in alcohol spend 4 In 2024, a leading consumer packaged goods company launched its first major U.S
MT-2 which is a cyclic 7-amino acid peptide)
Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial